Health Affairs May 7, 2020
With so much attention focusing on antibody testing, the opportunity to make outcomes of novel coronavirus (nCV) testing actionable is being overlooked and lost. As described below, there are health, policy, and economic benefits from a system documenting nCV exposure status.
For this post, “exposure” means having a record from a positive or negative nCV test result from an nCV RNA swab or an antibody test result specific to nCV. The term, “Immunity Registry” is not used as the presence of antibody and/or clearance of virus has not been yet proven to confer immunity or if it does, how long that immunity will last. But there is evidence from other coronaviruses for immunity; this is the rationale behind therapeutic use...
Today's Sponsors
Today's Sponsor